Susanne Embleton - Pharming Group Investor Mang
| PHARM Stock | EUR 0.90 0.02 2.27% |
Insider
Susanne Embleton is Investor Mang of Pharming Group NV
| Phone | 31 71 524 7400 |
| Web | https://www.pharming.com |
Pharming Group Management Efficiency
The company has return on total asset (ROA) of 0.0643 % which means that it generated a profit of $0.0643 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1669 %, meaning that it generated $0.1669 on every $100 dollars invested by stockholders. Pharming Group's management efficiency ratios could be used to measure how well Pharming Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Michele MBA | Galapagos NV | N/A | |
| Marieke Vermeersch | Galapagos NV | N/A | |
| John Montana | Galapagos NV | N/A | |
| Pim Berendsen | PostNL NV | 50 | |
| George Parthmer | AMG Advanced Metallurgical | N/A | |
| Ludo Mees | AMG Advanced Metallurgical | N/A | |
| Ganendran Sarvananthan | PostNL NV | 48 | |
| Joost Galen | Koninklijke BAM Groep | N/A | |
| Jeroen Veldstra | PostNL NV | N/A | |
| Jochem Laarschot | PostNL NV | N/A | |
| Capper | Koninklijke BAM Groep | N/A | |
| S Wynkele | Koninklijke BAM Groep | 54 | |
| Bart Delmulle | PostNL NV | N/A | |
| Timothy Lyle | Fugro NV | 46 | |
| Celine Gerson | Fugro NV | 51 | |
| Mark Heine | Fugro NV | 50 | |
| Hendrika Verhagen | PostNL NV | 57 | |
| Stefan Scherer | AMG Advanced Metallurgical | N/A | |
| Sofie Gijsel | Galapagos NV | N/A | |
| MBA MBA | Galapagos NV | 53 | |
| S Beckers | Koninklijke BAM Groep | N/A | |
Management Performance
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0643 |
Pharming Group NV Leadership Team
Elected by the shareholders, the Pharming Group's board of directors comprises two types of representatives: Pharming Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharming. The board's role is to monitor Pharming Group's management team and ensure that shareholders' interests are well served. Pharming Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharming Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bruno Giannetti, Consultant | ||
| Susanne Embleton, Investor Mang | ||
| Jeroen Wakkerman, Chief Officer | ||
| Ruud Outersterp, Chief Officer | ||
| Stephen Toor, Chief Americas | ||
| Anurag Relan, Chief Officer | ||
| MBA MD, CEO Pres | ||
| Mireille MSc, Chief Officer |
Pharming Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pharming Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0643 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 683.14 M | |||
| Shares Outstanding | 652.41 M | |||
| Shares Owned By Insiders | 1.97 % | |||
| Shares Owned By Institutions | 16.43 % | |||
| Price To Earning | 22.31 X | |||
| Price To Book | 3.85 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pharming Group in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pharming Group's short interest history, or implied volatility extrapolated from Pharming Group options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pharming Group NV using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Pharming Stock analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |